Arulanandam A - Search Results

1

Derivation and Preclinical Characterization of CYT-303, a Novel NKp46-NK Cell Engager Targeting GPC3.

Arulanandam A, Lin L, Chang HM, Cerutti M, Choblet S, Gao P, Rath A, Bensussan A, Kadouche J, Teper D, Mandelboim O, Li W. Arulanandam A, et al. Cells. 2023 Mar 24;12(7):996. doi: 10.3390/cells12070996. Cells. 2023. PMID: 37048069 Free PMC article.

2

KIR3DL3 Is an Inhibitory Receptor for HHLA2 that Mediates an Alternative Immunoinhibitory Pathway to PD1.

Bhatt RS, Berjis A, Konge JC, Mahoney KM, Klee AN, Freeman SS, Chen CH, Jegede OA, Catalano PJ, Pignon JC, Sticco-Ivins M, Zhu B, Hua P, Soden J, Zhu J, McDermott DF, Arulanandam AR, Signoretti S, Freeman GJ. Bhatt RS, et al. Among authors: arulanandam ar. Cancer Immunol Res. 2021 Feb;9(2):156-169. doi: 10.1158/2326-6066.CIR-20-0315. Epub 2020 Nov 23. Cancer Immunol Res. 2021. PMID: 33229411 Free PMC article.

3

Current strategies in the non-clinical safety assessment of biologics: New targets, new molecules, new challenges.

Brennan FR, Andrews L, Arulanandam AR, Blumel J, Fikes J, Grimaldi C, Lansita J, Loberg LI, MacLachlan T, Milton M, Parker S, Tibbitts J, Wolf J, Allamneni KP. Brennan FR, et al. Among authors: arulanandam ar. Regul Toxicol Pharmacol. 2018 Oct;98:98-107. doi: 10.1016/j.yrtph.2018.07.009. Epub 2018 Jul 17. Regul Toxicol Pharmacol. 2018. PMID: 30026135

4

Chronic neuropathic pain alleviation after transcranial direct current stimulation to the dorsolateral prefrontal cortex.

Arul-Anandam AP, Loo C, Martin D, Mitchell PB. Arul-Anandam AP, et al. Brain Stimul. 2009 Jul;2(3):149-51. doi: 10.1016/j.brs.2008.12.003. Epub 2009 Feb 28. Brain Stimul. 2009. PMID: 20633414 No abstract available.

5

Induction of hypomanic episode with transcranial direct current stimulation.

Arul-Anandam AP, Loo C, Mitchell P. Arul-Anandam AP, et al. J ECT. 2010 Mar;26(1):68-9. doi: 10.1097/YCT.0b013e3181a744bf. J ECT. 2010. PMID: 19483641

6

Transcranial direct current stimulation: a new tool for the treatment of depression?

Arul-Anandam AP, Loo C. Arul-Anandam AP, et al. J Affect Disord. 2009 Oct;117(3):137-45. doi: 10.1016/j.jad.2009.01.016. Epub 2009 Feb 7. J Affect Disord. 2009. PMID: 19201483 Review.

7

Transcranial direct current stimulation - what is the evidence for its efficacy and safety?

Arul-Anandam AP, Loo C, Sachdev P. Arul-Anandam AP, et al. F1000 Med Rep. 2009 Jul 27;1:58. doi: 10.3410/M1-58. F1000 Med Rep. 2009. PMID: 20948722 Free PMC article.

8

Effect of betel chewing, tobacco smoking and alcohol consumption on oral submucous fibrosis: a case-control study in Sri Lanka.

Ariyawardana A, Athukorala AD, Arulanandam A. Ariyawardana A, et al. Among authors: arulanandam a. J Oral Pathol Med. 2006 Apr;35(4):197-201. doi: 10.1111/j.1600-0714.2006.00400.x. J Oral Pathol Med. 2006. PMID: 16519765

9

Formation of human IFN-beta complex with the soluble type I interferon receptor IFNAR-2 leads to enhanced IFN stability, pharmacokinetics, and antitumor activity in xenografted SCID mice.

McKenna SD, Vergilis K, Arulanandam AR, Weiser WY, Nabioullin R, Tepper MA. McKenna SD, et al. Among authors: arulanandam ar. J Interferon Cytokine Res. 2004 Feb;24(2):119-29. doi: 10.1089/107999004322813363. J Interferon Cytokine Res. 2004. PMID: 14980076

10

The neutralization of type I IFN biologic actions by anti-IFNAR-2 monoclonal antibodies is not entirely due to inhibition of Jak-Stat tyrosine phosphorylation.

Novick D, Nabioullin RR, Ragsdale W, McKenna S, Weiser W, Garone L, Burkins C, Kim SH, Rubinstein M, Tepper MA, Arulanandam AR. Novick D, et al. Among authors: arulanandam ar. J Interferon Cytokine Res. 2000 Nov;20(11):971-82. doi: 10.1089/10799900050198417. J Interferon Cytokine Res. 2000. PMID: 11096454

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

21 results

Search Page